Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 7
2005 3
2006 3
2007 1
2008 4
2009 3
2010 7
2011 9
2012 13
2013 11
2014 9
2015 12
2016 7
2017 16
2018 9
2019 6
2020 7
2021 6
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS, Woodward WA. Rahal OM, et al. Among authors: reuben jm. Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):1034-1043. doi: 10.1016/j.ijrobp.2017.11.043. Epub 2017 Dec 7. Int J Radiat Oncol Biol Phys. 2018. PMID: 29485045 Free article.
Circulating tumor cells and coagulation-Minireview.
Bystricky B, Reuben JM, Mego M. Bystricky B, et al. Among authors: reuben jm. Crit Rev Oncol Hematol. 2017 Jun;114:33-42. doi: 10.1016/j.critrevonc.2017.04.003. Epub 2017 Apr 6. Crit Rev Oncol Hematol. 2017. PMID: 28477745 Review.
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.
Wang X, Semba T, Manyam GC, Wang J, Shao S, Bertucci F, Finetti P, Krishnamurthy S, Phi LTH, Pearson T, Van Laere SJ, Burks JK, Cohen EN, Reuben JM, Yang F, Min H, Navin N, Trinh VN, Iwase T, Batra H, Shen Y, Zhang X, Tripathy D, Ueno NT. Wang X, et al. Among authors: reuben jm. Sci Adv. 2022 Dec 16;8(50):eabn7983. doi: 10.1126/sciadv.abn7983. Epub 2022 Dec 16. Sci Adv. 2022. PMID: 36525493 Free PMC article.
Novel therapeutic strategies in the treatment of triple-negative breast cancer.
Oualla K, El-Zawahry HM, Arun B, Reuben JM, Woodward WA, Gamal El-Din H, Lim B, Mellas N, Ueno NT, Fouad TM. Oualla K, et al. Among authors: reuben jm. Ther Adv Med Oncol. 2017 Jul;9(7):493-511. doi: 10.1177/1758834017711380. Epub 2017 Jun 13. Ther Adv Med Oncol. 2017. PMID: 28717401 Free PMC article. Review.
Inflammatory breast cancer: what we know and what we need to learn.
Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, Iwamoto T, Krishnamurthy S, Yang W, Reuben JM, Hortobágyi GN, Ueno NT. Yamauchi H, et al. Among authors: reuben jm. Oncologist. 2012;17(7):891-9. doi: 10.1634/theoncologist.2012-0039. Epub 2012 May 14. Oncologist. 2012. PMID: 22584436 Free PMC article. Review.
The role of inflammation in inflammatory breast cancer.
Fouad TM, Kogawa T, Reuben JM, Ueno NT. Fouad TM, et al. Among authors: reuben jm. Adv Exp Med Biol. 2014;816:53-73. doi: 10.1007/978-3-0348-0837-8_3. Adv Exp Med Biol. 2014. PMID: 24818719 Review.
134 results